Secant Medical Expands Polymer Synthesis and Analytical Capabilities with New Lab

  Secant Medical Expands Polymer Synthesis and Analytical Capabilities with
  New Lab

Business Wire

PERKASIE, Pa. -- February 12, 2013

Secant Medical® has established a new lab to perform polymer synthesis and
analytical characterization of polymers, biomaterials and fibers. The
analytical and polymer synthesis lab boosts Secant Medical’s in-house services
for clients and enhances its biomaterials research and development.

“The study of biomaterials is moving toward examining the interface between
materials and biological systems. Our new lab affords us the ability to probe
this interface,” said Dr. Jeremy Harris, R&D Lab Manager at Secant Medical.

Capabilities include scanning electron microscopy, elemental detection,
infrared spectroscopy and imaging, UV/Vis spectrophotometry, melt-flow
rheometry, differential scanning calorimetry, thermogravimetric analysis, and
light microscopy.

“With this lab, Secant Medical has the tools to develop biomaterials, because
it gives us a deeper understanding of the interaction of biomaterials, from
their composition and interaction with cell biology to how they will
ultimately impact device technology,” said Peter Gabriele, Director, Emerging
Technology at Secant Medical. “Biomaterials are in themselves an emerging
technology. We have to understand how they behave and perform beyond the
mechanical analysis—we must understand the chemical analysis.”

The lab is fully operational and driven by a team of chemists, chemical
engineers, microbiologists and biomaterial engineers. The real-time analysis
of raw materials to finished goods provides a state-of-the-art approach to
quality by addressing and solving material concerns with a more efficient
turnaround time.

About Secant Medical: Secant Medical® designs and manufactures biomedical
textiles and other structures for medical devices. Employing medical fabric
engineering technologies, we blend polymeric, metallic and resorbable
biomaterials to create custom, high-performance structures that are used in
the cardiovascular, general surgery, neurovascular, orthopedic and
regenerative medicine fields. Built on a 70-year history, we’re committed to
the future of biomaterials and their role in the healing process and are
actively engaged in research partnerships to advance next-generation
biomaterial development. Secant Medical is a business unit of Fenner PLC, a
worldwide leader in reinforced polymer engineering headquartered in Yorkshire,
England. For more information, contact Maria Fontanazza at 215-257-8680 x2192
or maria.fontanazza@secantmedical.com; or visit
http://www.secantmedical.com/release-entry.php.

Contact:

Secant Medical
Maria Fontanazza, 215-257-8680 x2192
maria.fontanazza@secantmedical.com
 
Press spacebar to pause and continue. Press esc to stop.